The weekly litigation news digest is live. Subscribe now

IP Verse

Salt Of Pyrrolo[2,3-D]Pyrimidine Compound And Novel Polymorph Of Salt - EP3231805

The patent EP3231805 was granted to Crystal Pharmatech on Mar 4, 2020. The application was filed on Dec 11, 2015 under application number EP15867450A. The patent is currently recorded with a legal status of "Revoked".

EP3231805

CRYSTAL PHARMATECH
Application Number
EP15867450A
Filing Date
Dec 11, 2015
Status
Revoked
Jul 15, 2022
Publication Date
Mar 4, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SCORPIODec 4, 2020SAGITTARIUSADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTCN102186856
INTERNATIONAL-SEARCH-REPORTCN103201275
INTERNATIONAL-SEARCH-REPORTCN105085533
INTERNATIONAL-SEARCH-REPORTCN105111215
OPPOSITIONCN110156793
OPPOSITIONCN110964017
OPPOSITIONWO2010020675
OPPOSITIONWO2012064805
OPPOSITIONWO2019019959
OPPOSITIONWO2019040567
OPPOSITIONWO2019111160
OPPOSITIONWO2019142206
OPPOSITIONWO2020225827
SEARCHWO2010020675
SEARCHWO2012064805

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents